ACE inhibitor and ARB therapy: Practical recommendations

Cleve Clin J Med. 2019 Sep;86(9):608-611. doi: 10.3949/ccjm.86a.19016.

Author

Hernan Rincon-Choles^{1

2

3}

Affiliations

¹ Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. rinconh@ccf.org.
² Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
³ Medical Director of the East Cleveland Dialysis Center, Ohio Renal Care Group, East Cleveland, OH, USA.

PMID: 31498762
DOI: 10.3949/ccjm.86a.19016

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors*
Humans
Potassium*

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Potassium